Trinkmann, Frederik http://orcid.org/0000-0001-5877-877X
Lenz, Steffi A.
Schäfer, Julia
Gawlitza, Joshua
Schroeter, Michele
Gradinger, Tobias
Akin, Ibrahim
Borggrefe, Martin
Ganslandt, Thomas http://orcid.org/0000-0001-6864-8936
Saur, Joachim
Article History
Received: 9 August 2019
Accepted: 15 January 2020
First Online: 30 January 2020
Competing interests
: The authors declare no conflict of interest directly related to the content of the manuscript. The following financial activities outside the submitted work exist: F. Trinkmann received travel support from Actelion, Berlin Chemie, Boehringer Ingelheim, Chiesi, Novartis, Mundipharma and TEVA as well as speaker or consultation fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, GlaxoSmithKline, Roche and Novartis. J. Saur received travel support and speaker fees from Boehringer Ingelheim, GlaxoSmithKline, Novartis und Roche. M. Borggrefe received speaker or consultation fees from Bayer, Boehringer Ingelheim, Daiichi Sankyo, Impulse Dynamics and Zoll Medical. I. Akin received travel support as well as speaker or consultation fees from Abiomed, Bayer, Boehringer Ingelheim und St. Jude Medical.